Neurasthenia: History, Symptoms, and Modern Diagnostic Status
Author: Ukrainian Psychological Hub · Published: September 30, 2026 · Editorial Policy
Ukrainian Psychological Hub — Psychology for the AI Era
Published September 30, 2026 · Editorial Policy
Neurasthenia was a historical diagnosis centered on mental and physical exhaustion, weakness, reduced capacity for effort, sleep and concentration problems, headaches, pain, irritability, and other bodily complaints. It became one of the most influential diagnoses of the late nineteenth and early twentieth centuries after the American neurologist George Miller Beard gave the condition a recognizable medical form in 1869. Beard’s original 1869 paper described what he called nervous exhaustion, but the category expanded rapidly and acquired different meanings in different countries and medical traditions.
For a modern reader, the most important point is classification. Neurasthenia is not a diagnosis in DSM-5-TR, the current text revision of the American Psychiatric Association’s DSM published in 2022. The APA describes DSM-5-TR as the current DSM diagnostic classification. The World Health Organization’s ICD-10 did retain neurasthenia as F48.0 under “Other neurotic disorders,” but ICD-11 does not preserve it as a standalone diagnosis. ICD-11 instead reorganized this territory, including some of the conceptual ground formerly covered by ICD-10 neurasthenia within bodily distress disorder. That is a classification history, not a one-to-one diagnostic conversion.
Neurasthenia therefore has no single modern equivalent. A person who would once have received that label might today require assessment for a depressive disorder, an anxiety disorder, a sleep disorder, a medical cause of fatigue, a pain condition, myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), bodily distress disorder, another condition, or no psychiatric diagnosis at all. Historical overlap never makes these categories interchangeable.
What Does Neurasthenia Mean?
The word neurasthenia is usually translated as “nervous weakness” or “nervous exhaustion.” In its classic late-nineteenth-century form, it named a presumed disorder of depleted nervous energy. Beard treated the nervous system as if it had a limited reserve that could be exhausted by the demands of modern life. In his framework, excessive intellectual work, business pressure, urban stimulation, technological change, worry, and other stresses of modern civilization could consume nervous force and produce a wide range of mental and bodily symptoms.
That theory was historically influential because it offered a physical-sounding explanation for suffering that did not fit obvious structural disease. It also gave patients and physicians a language for combinations of exhaustion, cognitive difficulty, pain, insomnia, digestive complaints, emotional distress, sexual symptoms, and reduced ability to work. A JAMA historical review of neurasthenia in modernizing America describes the diagnosis as a culturally oriented medical category built around the nineteenth-century idea of nervous energy.
The historical category was unusually broad. It did not correspond to one stable symptom set, one mechanism, or one population across its history. That breadth helps explain both its popularity and its eventual decline. Modern readers should therefore resist treating “neurasthenia” as if it were an old spelling of one present-day disorder.
Within the English Psychology Hub, the broader historical umbrella is explained in Neurosis: What It Means Today, Symptoms, History, and Modern Diagnoses, while the distinction between the umbrella term and this specific exhaustion diagnosis is covered in Neurosis vs Neurasthenia: Historical Terms, Symptoms, and Modern Classification.
The Historical Origin of Neurasthenia
George Beard and the 1869 formulation
George Miller Beard’s 1869 article in the Boston Medical and Surgical Journal is the conventional starting point for neurasthenia as a major modern medical diagnosis. Although the word had antecedents, Beard’s work gave the concept a distinctive clinical and cultural identity. He later expanded it in books on nervous exhaustion and American nervousness.
Beard’s central claim was physiological by the standards of his time: the nervous system could lose its usable energy. That loss was supposed to manifest through exhaustion and a remarkably diverse collection of symptoms. The model fit a period fascinated by electricity, energy, speed, telegraphy, railroads, industrial work, and the changing tempo of urban life. Historical scholarship has therefore treated neurasthenia as both a medical diagnosis and a diagnostic expression of nineteenth-century modernity. Lian and Bondevik’s analysis of long-term exhaustion describes how neurasthenia medicalized long-term exhaustion and became highly prominent from the late nineteenth century into the early twentieth.
Beard’s biological explanation is not a modern scientific account of fatigue. There is no current evidence base validating a generalized reservoir of “nerve-force” that is depleted in the way his theory proposed. The historical importance of the model lies in what it organized: symptoms, social anxieties, clinical practices, and a way of interpreting exhaustion.
From an “American disease” to an international diagnosis
Neurasthenia quickly escaped its American setting. Jean-Martin Charcot and other European neurologists adopted and reshaped the diagnosis, helping turn it into an international category. Christopher Goetz’s historical study of Charcot documents Charcot’s role in internationalizing the diagnosis while continuing to credit Beard’s original formulation.
Once the label crossed national boundaries, it did not remain conceptually identical. Medical cultures emphasized different symptoms, causes, social meanings, and treatment strategies. In some settings, exhaustion and physical weakness stayed central. In others, anxiety, low mood, bodily distress, digestive complaints, headache, sexual symptoms, or impaired concentration became especially prominent. This cultural variability later mattered greatly when international diagnostic systems attempted to define neurasthenia operationally.
What Symptoms Were Historically Included in Neurasthenia?
Historical symptom descriptions were broad and variable. Fatigue was central, but “fatigue” itself could mean mental exhaustion, physical weakness, rapid tiring, inability to sustain work, or a persistent sense of depleted capacity. Beard’s broader writings attached many other complaints to the condition, which is one reason later historians describe neurasthenia as an unstable and highly elastic category.
Commonly described historical features included reduced endurance, weakness after small efforts, difficulty concentrating, forgetfulness, inefficient thinking, headache, dizziness, disturbed sleep, inability to relax, irritability, low mood, anxiety, muscular aches and pains, digestive complaints, sexual difficulties, palpitations, sensory sensitivity, and generalized feelings of bodily instability. The exact list varied by author, period, and country.
The World Health Organization eventually narrowed this tradition when it formalized neurasthenia in ICD-10. WHO’s ICD-10 Clinical Descriptions and Diagnostic Guidelines described two overlapping presentations. One emphasized increased fatigue after mental effort with reduced occupational performance or everyday coping and difficulty concentrating. The other emphasized bodily weakness and exhaustion after minimal physical effort, often with muscular aches, pain, and inability to relax.
ICD-10 also listed associated features such as dizziness, tension headaches, sleep disturbance, irritability, dyspepsia, mild anxiety, and mild depressive symptoms. Crucially, the ICD-10 description required that autonomic or depressive symptoms not be severe and persistent enough to satisfy criteria for a more specific disorder. The same guideline explicitly instructed clinicians to consider depressive and anxiety disorders in differential diagnosis.
These historical and ICD-10 descriptions should not be turned into a modern self-test. Fatigue, poor concentration, sleep disturbance, pain, irritability, headache, and dizziness are nonspecific symptoms. They occur in many psychiatric, neurological, sleep, endocrine, infectious, cardiovascular, inflammatory, medication-related, and other medical contexts. The more general problem of translating old symptom language is covered in Neurosis Symptoms: What the Historical Term Included and What Symptoms May Mean Today.
Neurasthenia Was More Than a Symptom List
A historical diagnosis is a package of assumptions: which symptoms belong together, what causes them, which clinicians claim authority over them, how patients understand them, and which treatments appear rational. Neurasthenia changed because every part of that package changed.
In Beard’s model, the symptoms expressed nervous depletion. In later neurological practice, neurasthenia could overlap with other functional or “nervous” illnesses. Psychoanalytic writers reinterpreted parts of the same clinical territory in psychological and psychosexual terms. International classifications later tried to transform this flexible historical label into explicit criteria. Cultural psychiatry then showed that the same word could function differently across societies.
This is why an old chart entry reading “neurasthenia” cannot be translated mechanically into a current diagnosis. The label tells us something about the physician’s diagnostic language and the patient’s era. It does not, by itself, reveal what a clinician using DSM-5-TR or ICD-11 would diagnose today.
Neurasthenia and Early Psychoanalysis
Neurasthenia also entered the history of psychoanalysis, but the relationship is often simplified. Freud did not merely adopt Beard’s diagnosis unchanged. In his theory of the “actual neuroses,” he differentiated neurasthenia from anxiety neurosis and proposed etiological mechanisms that belonged to his own late-nineteenth-century psychosexual framework.
A historical analysis by Malcolm Macmillan comparing Beard’s neurasthenia with Freud’s actual neuroses shows both similarities and important differences between the two theories. Macmillan’s historical critique also emphasizes that the causal theories proposed by Beard and Freud are not supported as modern scientific explanations.
For contemporary use, “neurasthenia” as a Beardian nervous-exhaustion diagnosis and “neurasthenia” as a term within Freud’s early theory should therefore be identified by theoretical context. Neither historical construct can be imported wholesale into current psychiatric diagnosis.
Why Did Neurasthenia Decline?
Neurasthenia did not vanish because medicine discovered one disease that was its true hidden identity. Its territory fragmented. More specific psychiatric diagnoses developed; neurology changed its explanatory models; psychoanalytic concepts redirected some patients and symptoms; internal medicine identified additional causes of fatigue and pain; and psychiatric classification increasingly favored narrower categories with explicit criteria.
Historical hospital data support this idea of diagnostic redistribution. Ruth Taylor’s study of Queen Square Hospital records from 1870 to 1932 found that neurasthenia once accounted for a substantial share of discharges and then virtually disappeared around 1930 in that institution. Taylor concluded that the patients and problems did not simply disappear; the diagnostic language changed and cases were reclassified.
The decline was also cultural. The modernity that Beard regarded as pathological became ordinary life. Electricity, fast communication, office work, expanding education, women’s changing social roles, and urban complexity could no longer function in the same way as distinctive causal explanations for one disease. Meanwhile, medicine’s standards for diagnostic validity were changing.
The result was not one replacement diagnosis but a dispersal across different domains. This is also why Types of Neurosis: Historical Categories and Their Modern Equivalents treats historical labels as lineages and mappings rather than synonyms.
Neurasthenia in DSM: What Is Its Current Status?
Neurasthenia is not a current DSM-5-TR diagnosis. DSM-5-TR, published by the American Psychiatric Association in 2022, organizes mental disorders into contemporary diagnostic categories with defined criteria sets and differential diagnoses. The APA’s official DSM-5-TR overview explains the role of the DSM diagnostic classification and criteria.
The absence of neurasthenia from DSM-5-TR matters because many web explanations use the word as though it were a current American psychiatric diagnosis. It is more accurate to describe it as a historical or legacy diagnosis when discussing present-day DSM practice.
It is equally important not to confuse absence from DSM-5-TR with proof that every symptom historically called neurasthenia was “not real.” Diagnostic systems classify patterns; they do not make fatigue, pain, poor sleep, cognitive difficulty, or distress disappear when a label changes. What changes is the framework used to investigate and classify those experiences.
For the broader classification question, see Is Neurosis Still a Diagnosis? DSM-5-TR, ICD-11, and Modern Psychiatry.
Neurasthenia in ICD-10: F48.0
The ICD history is different from the DSM history. WHO’s ICD-10 retained neurasthenia as F48.0 under “Other neurotic disorders.” The retention was deliberate. The ICD-10 clinical guidelines noted that the diagnosis remained widely used in a number of countries and that some cases diagnosed as neurasthenia did not fit another category neatly.
The ICD-10 description is especially useful historically because it shows an attempt to discipline a very broad nineteenth-century diagnosis. Rather than reproducing Beard’s enormous range of complaints, ICD-10 centered persistent distressing mental fatigue after effort or persistent bodily weakness and exhaustion after minimal effort, with additional symptoms such as muscular pain, dizziness, tension headache, sleep disturbance, inability to relax, irritability, or dyspepsia.
ICD-10 also contained exclusions that are highly relevant today. Its neurasthenia section excluded burn-out, malaise and fatigue, postviral fatigue syndrome, and psychasthenia from F48.0. That alone is enough to reject a common internet shortcut: “neurasthenia” was not simply another name for every fatigue condition even within ICD-10.
The phrase “ICD-10 diagnosis” must also be dated. ICD-10’s retention of F48.0 does not mean that ICD-11 continues the same standalone category. Classification status belongs to a specific revision.
What Happened to Neurasthenia in ICD-11?
ICD-11 does not retain neurasthenia as a standalone mental-disorder diagnosis. WHO’s current ICD-11 Clinical Descriptions and Diagnostic Requirements for mental, behavioral and neurodevelopmental disorders belongs to a substantially reorganized classification.
The development literature makes the transition clearer. Reed and colleagues’ account of changes in the ICD-11 mental-disorders classification explains that ICD-11 bodily distress disorder replaced the ICD-10 somatoform-disorder grouping and also includes the concept of ICD-10 neurasthenia. Bodily distress disorder is characterized by distressing bodily symptoms together with excessive attention directed toward them; it is not defined merely by fatigue and it is not a renamed F48.0.
This distinction prevents a misleading crosswalk. Saying that ICD-11 bodily distress disorder “includes the concept” of ICD-10 neurasthenia describes a classificatory reorganization. It does not establish that every former F48.0 case now meets ICD-11 bodily distress disorder criteria. Some people formerly labeled neurasthenic may instead fit mood, anxiety, sleep, neurological, medical, or other categories; others may not satisfy a psychiatric diagnosis.
Cultural psychiatry has also raised concerns about what is lost when a widely used local category disappears. Sharan and Hans’s review of cultural issues in ICD-11 specifically lists neurasthenia among ICD-10 disorders omitted in ICD-11 and discusses the possible cultural consequences of this simplification.
Is Neurasthenia the Same as ME/CFS?
No. Neurasthenia and myalgic encephalomyelitis/chronic fatigue syndrome have historical and phenomenological overlap around fatigue, but they are not interchangeable diagnoses. ICD-10 itself excluded postviral fatigue syndrome from F48.0. Modern ME/CFS is assessed using its own clinical criteria and medical differential.
The U.S. Centers for Disease Control and Prevention describes ME/CFS as a condition involving substantial impairment with fatigue, post-exertional malaise, unrefreshing sleep, and cognitive impairment and/or orthostatic intolerance, after appropriate clinical evaluation. CDC guidance on diagnosing ME/CFS also emphasizes that there is no single confirmatory diagnostic test and that clinicians must evaluate other possible causes of fatigue.
The distinction is clinically important because the historical neurasthenia literature often used “exhaustion after effort” in a broad way, whereas post-exertional malaise in ME/CFS has a specific modern meaning involving symptom worsening after activity. Similar words do not make the underlying diagnostic constructs equivalent.
A review devoted specifically to this question, Starcevic’s cross-cultural analysis of neurasthenia and chronic fatigue syndrome, concluded that neurasthenia was too heterogeneous across cultures to be treated as a simple universal counterpart of chronic fatigue syndrome.
Is Neurasthenia the Same as Depression?
No. Historical neurasthenia often included low mood, anhedonia, poor sleep, reduced motivation, pain, fatigue, and concentration problems, so overlap with depressive disorders is unsurprising. But overlap does not establish identity.
A landmark 1982 cultural-psychiatry study by Arthur Kleinman examined 100 patients diagnosed with neurasthenia in a psychiatric outpatient clinic in Hunan, China. Eighty-seven met DSM-III criteria for major depressive disorder, and anxiety diagnoses were also frequent. This finding became influential because it demonstrated how the same patients could be organized differently by different diagnostic systems.
The correct inference is limited. The study concerned a specific clinical population, a specific historical moment, and DSM-III criteria. It does not prove that “neurasthenia means depression.” It shows substantial diagnostic overlap in that sample and highlights the role of culture and classification in how distress is named.
Later cultural work complicates any simple translation. Sing Lee’s analysis of neurasthenia in contemporary Chinese society argued that the Chinese illness experience should not be reduced to a physical disorder, a somatoform disorder, or chronic fatigue alone.
Is Neurasthenia the Same as an Anxiety Disorder?
No. Anxiety, irritability, autonomic sensations, sleep difficulty, poor concentration, and fatigue frequently appeared within historical descriptions of neurasthenia, and ICD-10 instructed clinicians to rule out anxiety disorders when they better accounted for the presentation. Yet there is no one-to-one relationship between neurasthenia and any current anxiety diagnosis.
The historical umbrella captured people with different symptom configurations. Some might meet modern criteria for generalized anxiety disorder or another anxiety disorder; others would not. Modern anxiety diagnoses are defined by their own criteria, duration requirements, functional impact, and differential diagnosis. A vague historical label cannot substitute for that assessment.
Is Neurasthenia the Same as Burnout?
No. Both words can evoke exhaustion, but their classification histories and intended scope are different. The World Health Organization defines burn-out in ICD-11 as an occupational phenomenon resulting from chronic workplace stress that has not been successfully managed. WHO explicitly states that burn-out is not classified as a medical condition and that the concept refers specifically to the occupational context.
Neurasthenia, by contrast, was a historical medical and psychiatric diagnosis whose complaints were not restricted to work. The ICD-10 neurasthenia section even listed burn-out as an exclusion. Using “neurasthenia” as an ornate synonym for burnout erases that historical and classificatory distinction.
Neurasthenia, Somatic Symptoms, and Bodily Distress
Neurasthenia has often been placed near the history of somatic symptom concepts because physical complaints were prominent and obvious structural disease was often absent. Yet “somatic” should not be used as a synonym for imaginary. Pain, dizziness, fatigue, sleep disturbance, gastrointestinal symptoms, and weakness are real experiences regardless of how their mechanisms are eventually classified.
ICD-11 bodily distress disorder is also not defined by the claim that symptoms are medically unexplained. Reed and colleagues emphasize that the diagnosis depends on distressing bodily symptoms and excessive attention directed toward them. A medical condition can coexist with bodily distress disorder if the psychiatric criteria are independently met.
Historical neurasthenia lacked this precise modern architecture. Its broad physical symptom territory is explored in Physical Symptoms of Neurosis: Historical Somatic Complaints and Modern Differential Diagnosis, which focuses on how old somatic language should be interpreted without turning it into a present-day diagnosis.
Neurasthenia in China: Why Culture Changes the Meaning of a Diagnosis
The history of neurasthenia in China is one of the strongest demonstrations that psychiatric terms do not travel as empty labels. The Chinese term shenjing shuairuo became embedded in local medical practice and everyday understandings of distress. It could organize physical exhaustion, cognitive complaints, emotional suffering, work problems, and social strain in ways that did not map cleanly onto Western diagnostic assumptions.
Kleinman’s 1982 study drew global attention to the overlap between Chinese neurasthenia and DSM-III major depression. Later work showed that this was only part of the story. Lee’s 1998 cultural analysis argued against reducing neurasthenia to a single Western category. In 2007, Lee and Kleinman reviewed how the diagnosis changed over time in China and described its declining professional use as DSM-derived categories became more influential.
These studies matter for two reasons. First, they show that diagnostic labels can serve as culturally intelligible idioms for suffering, work difficulty, family conflict, and bodily experience. Second, they warn against assuming that replacing one label with another is a purely technical act. Classification changes can alter which experiences become visible, how patients describe them, and which forms of help seem legitimate.
This cultural history should not be romanticized either. A historically familiar label can obscure a depressive disorder, anxiety disorder, pain condition, neurological disorder, sleep disorder, or other treatable problem if clinicians stop at the old name. Cultural validity and clinical differential diagnosis have to operate together.
Did Neurasthenia Have a Single Cause?
Historically, no consensus existed, even when authors used the same word. Beard emphasized nervous depletion and modern civilization. Other physicians proposed heredity, overwork, infection, sexual factors, digestive dysfunction, toxins, constitutional weakness, emotional conflict, or combinations of bodily and psychological processes. Psychoanalytic theories introduced still other mechanisms.
Modern evidence does not support restoring these heterogeneous explanations as one unified causal model. A contemporary clinician confronted with persistent exhaustion should ask a different question: what process or combination of processes best explains this person’s symptoms now? The answer may involve sleep, mood, anxiety, autonomic function, infection, medication, endocrine disease, anemia, chronic pain, ME/CFS, psychosocial stress, or many other possibilities.
The scientific lesson from neurasthenia is therefore methodological. A symptom cluster can be coherent enough to become socially and medically powerful long before its mechanism is established. Diagnostic popularity is not evidence of causal unity.
Historical Treatment of Neurasthenia
Treatment followed the theory. If nervous energy was depleted, physicians tried to conserve or restore it. Rest, isolation from ordinary demands, dietary regimens, massage, electrical treatments, tonics, travel, exercise in selected cases, and structured routines all appeared in the therapeutic landscape. S. Weir Mitchell’s “rest cure” became especially famous, although physicians varied greatly in how they treated men, women, wealthy patients, and working patients.
Historical treatments are part of the history of medicine, not a modern treatment protocol. Their rationales depended on the diagnostic models of their time. Some practices offered rest, attention, nutrition, or temporary relief from overwhelming demands; others imposed restrictive regimens that modern readers may reasonably find troubling.
There is no evidence-based treatment package today called “treatment for neurasthenia” within DSM-5-TR or ICD-11 because there is no single current diagnosis with that name across those systems. Modern treatment should target the condition actually established after assessment.
What Would a Modern Clinician Do With “Neurasthenia” Symptoms?
A modern evaluation begins with the symptoms rather than with the historical label. Persistent fatigue and weakness require attention to onset, duration, severity, activity intolerance, sleep, mood, anxiety, pain, medications and substances, infections, medical history, functional change, and other associated symptoms. Physical examination and laboratory testing may be appropriate depending on the presentation.
The purpose is differential diagnosis, not forced translation. A person may have one condition, several overlapping conditions, or a symptom pattern that remains incompletely explained after an initial evaluation. Modern diagnostic reasoning allows uncertainty to remain visible while additional information is gathered.
ME/CFS provides a useful example of why precision matters. CDC guidance requires assessment of characteristic features such as post-exertional malaise and unrefreshing sleep while also ruling out other causes of fatigue. A nineteenth-century label cannot supply those modern criteria retrospectively.
Likewise, low mood plus fatigue does not automatically establish a depressive disorder; worry plus exhaustion does not automatically establish generalized anxiety disorder; and work-related exhaustion does not automatically establish burnout. Each construct has its own scope.
When Does Persistent Fatigue Need Medical Evaluation?
Persistent or functionally significant fatigue deserves clinical evaluation when it is new, worsening, prolonged, or accompanied by other concerning symptoms. The reason is straightforward: fatigue is a cross-cutting symptom with a broad differential. It can arise from sleep problems, psychiatric conditions, infections, anemia, endocrine conditions, medication effects, cardiovascular or pulmonary disease, neurological illness, chronic pain, ME/CFS, and other causes.
Urgent assessment is appropriate when fatigue or weakness occurs with severe shortness of breath, chest pain, fainting, sudden or focal neurological changes, severe dehydration, major bleeding, rapidly progressive weakness, or other signs of an acute medical problem. The historical category of neurasthenia should never be used to explain away warning signs.
For nonurgent persistent symptoms, bringing a clinician a concrete record is often more useful than asking whether one “has neurasthenia.” Useful details include when symptoms began, what worsens or relieves them, how activity affects symptoms, sleep quality, associated pain or dizziness, recent infections, medication changes, and the effect on work, study, relationships, and daily tasks.
What Does an Old Medical Record Saying “Neurasthenia” Mean Today?
If an ancestor, historical patient, or older medical record carries a neurasthenia diagnosis, the safest interpretation is historical first. The term tells you that a clinician used a diagnostic vocabulary in which nervous exhaustion or related complaints were grouped under that name.
To reconstruct what the patient actually experienced, look for the record’s date, country, medical specialty, symptom description, duration, physical findings, treatments, and any competing diagnoses. A neurasthenia diagnosis made in 1895 Paris, 1920 London, 1982 Hunan, or an ICD-10-based service in the late twentieth century did not necessarily mean the same thing.
Retrospective diagnosis should remain limited. Historical records rarely contain the information required to apply modern criteria reliably, and current criteria were not designed to be imposed mechanically on incomplete historical cases.
What Neurasthenia Does and Does Not Map Onto Today
Possible modern areas of assessment
Historical neurasthenia can overlap phenomenologically with several modern domains: depressive symptoms, anxiety symptoms, sleep disturbance, chronic pain, bodily distress, medically explained fatigue, medically unexplained fatigue, autonomic symptoms, cognitive complaints, and ME/CFS. The word “overlap” is the key term. It identifies shared features without declaring diagnostic equivalence.
In some historical cohorts, many patients could be reclassified into newer psychiatric categories. In others, the old diagnosis represented a broader cultural idiom or a symptom combination that remained difficult to place. This heterogeneity is one reason Starcevic’s review concluded that the overall diagnostic validity of neurasthenia was unsatisfactory.
No single successor
There is no scientifically justified formula such as “neurasthenia = depression,” “neurasthenia = anxiety,” “neurasthenia = ME/CFS,” “neurasthenia = burnout,” or “neurasthenia = bodily distress disorder.” Each equation collapses classification history into a false synonym.
The better model is branching. One old category covered multiple symptom patterns. As diagnostic systems changed, those patterns were redistributed into several categories and medical differentials. ICD-11’s inclusion of the ICD-10 neurasthenia concept within bodily distress disorder is one branch of that story, not the whole story.
Common Misconceptions About Neurasthenia
“Neurasthenia is just an old word for chronic fatigue syndrome.”
This is too simple. Historical neurasthenia was culturally and diagnostically heterogeneous, and ICD-10 explicitly excluded postviral fatigue syndrome from F48.0. Modern ME/CFS has its own diagnostic framework, including post-exertional malaise.
“Neurasthenia was really depression.”
Some historical and cross-cultural samples showed major overlap with depressive disorders, including Kleinman’s influential Hunan study, but overlap in a sample does not establish semantic identity across all periods and cultures.
“Neurasthenia is the medical name for burnout.”
It is not. WHO classifies burn-out in ICD-11 as an occupational phenomenon, not a medical condition, and limits the concept to the work context. ICD-10 listed burn-out separately from neurasthenia.
“Because neurasthenia disappeared, the illness was imaginary.”
Diagnostic disappearance does not imply that symptoms were invented. People experienced fatigue, pain, insomnia, cognitive difficulty, anxiety, low mood, and functional impairment. What changed was the model used to organize those experiences.
“ICD-10 F48.0 means neurasthenia is still a current ICD-11 diagnosis.”
Classification versions cannot be mixed. ICD-10 retained F48.0; ICD-11 does not retain a standalone neurasthenia diagnosis.
Neurasthenia as a Case Study in the History of Diagnosis
Neurasthenia is unusually valuable because its life cycle is visible. A new diagnostic idea appeared, spread internationally, accumulated symptoms, became culturally meaningful, entered competing theories, was formalized in classification systems, and then lost its former status. The patients did not vanish when the category declined. Their symptoms moved through new explanatory and diagnostic structures.
That history shows why diagnostic categories should be read at two levels. At the clinical level, they guide recognition, differential diagnosis, communication, and treatment. At the historical level, they also reveal what medicine at a given time believed counted as a coherent disorder.
Neurasthenia’s trajectory from Beard to ICD-10 and then out of ICD-11 as a standalone category is therefore more informative than a simple claim that the diagnosis was “wrong.” It shows how psychiatry and medicine revise the boundaries of disorders as evidence, theory, culture, and classification standards change.
Practical Interpretation for a Modern Reader
If you encounter “neurasthenia” in a book, old medical record, psychoanalytic text, or historical article, first identify the date and framework. Ask whether the author means Beard’s nervous exhaustion, a later neurological diagnosis, Freud’s use within the theory of actual neuroses, an ICD-10 F48.0 diagnosis, a Chinese cultural-clinical category, or a loose nontechnical synonym for exhaustion.
If you encounter the word in contemporary online health content, check whether the author specifies DSM-5-TR, ICD-10, or ICD-11. A page that simply says “neurasthenia is a mental disorder” without naming the classification can collapse distinct eras.
If you are trying to understand your own symptoms, translate the question from “Do I have neurasthenia?” to “What is causing my fatigue, weakness, sleep problems, pain, concentration difficulty, or distress?” That question is compatible with modern clinical assessment and does not presuppose an obsolete umbrella diagnosis.
Frequently Asked Questions
Is neurasthenia a real diagnosis today?
Its status depends on the classification and period. Neurasthenia was a major historical diagnosis and was retained as F48.0 in ICD-10. It is not a diagnosis in DSM-5-TR, and ICD-11 does not retain it as a standalone diagnosis.
What were the main symptoms of neurasthenia?
Historical descriptions emphasized mental or physical fatigue, weakness, reduced efficiency, poor concentration, sleep disturbance, headache, dizziness, pain, irritability, difficulty relaxing, digestive complaints, and varying anxiety or low mood. The mix changed across authors, countries, and periods.
Who introduced neurasthenia?
George Miller Beard is conventionally credited with establishing and popularizing the modern diagnostic concept through his 1869 work on nervous exhaustion, although the word had earlier antecedents.
Was neurasthenia a neurological or psychiatric disorder?
Historically it crossed boundaries. Beard and many early practitioners framed it as a neurological or physiological exhaustion disorder. Later psychiatric and psychoanalytic interpretations expanded. ICD-10 eventually placed it in the mental and behavioral disorders chapter as F48.0.
What replaced neurasthenia?
No single diagnosis replaced it. Its former territory was distributed among mood, anxiety, somatic/bodily distress, sleep, pain, neurological, fatigue-related, and other medical or psychiatric categories. ICD-11 bodily distress disorder incorporates part of the ICD-10 neurasthenia concept, but is not a universal successor.
Is neurasthenia the same as chronic fatigue?
No. Chronic fatigue is a symptom description, and ME/CFS is a modern clinical condition with its own criteria. Historical neurasthenia was broader and more variable.
Is neurasthenia the same as nervous breakdown?
No. “Nervous breakdown” is an informal phrase without one standardized modern diagnosis. Neurasthenia had specific historical diagnostic uses and, in ICD-10, an explicit F48.0 category.
Can neurasthenia be self-diagnosed from a symptom list?
A historical symptom list cannot establish a modern diagnosis. The core symptoms are nonspecific, and persistent fatigue or weakness can have many psychiatric and medical causes.
Why is neurasthenia still discussed?
It remains important in the history of psychiatry, neurology, psychosomatic medicine, psychoanalysis, cultural psychiatry, and the study of fatigue. It also helps explain why old diagnoses cannot be translated into modern categories by simple synonym.
Related Articles
References
American Psychiatric Association. (2022). About DSM-5-TR. Official APA resource.
Beard, G. M. (1869). Neurasthenia, or nervous exhaustion. Boston Medical and Surgical Journal, 80, 217–221. https://doi.org/10.1056/NEJM186904290801301.
Centers for Disease Control and Prevention. (2024). Diagnosing ME/CFS. CDC.
Goetz, C. G. (2001). Poor Beard!! Charcot’s internationalization of neurasthenia, the “American disease.” Neurology, 57(3), 510–514. https://doi.org/10.1212/WNL.57.3.510.
Kleinman, A. (1982). Neurasthenia and depression: A study of somatization and culture in China. Culture, Medicine and Psychiatry, 6(2), 117–190. https://doi.org/10.1007/BF00051427.
Lee, S. (1998). Estranged bodies, simulated harmony, and misplaced cultures: Neurasthenia in contemporary Chinese society. Psychosomatic Medicine, 60(4), 448–457. https://doi.org/10.1097/00006842-199807000-00010.
Lee, S., & Kleinman, A. (2007). Are somatoform disorders changing with time? The case of neurasthenia in China. Psychosomatic Medicine, 69(9), 846–849. https://doi.org/10.1097/PSY.0b013e31815b0092.
Lian, O. S., & Bondevik, H. (2015). Medical constructions of long-term exhaustion, past and present. Sociology of Health & Illness, 37(6), 920–935. https://doi.org/10.1111/1467-9566.12249.
Macmillan, M. B. (1976). Beard’s concept of neurasthenia and Freud’s concept of the actual neuroses. Journal of the History of the Behavioral Sciences, 12(4), 376–390. PubMed.
Reed, G. M., First, M. B., Kogan, C. S., et al. (2019). Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry, 18(1), 3–19. https://doi.org/10.1002/wps.20611.
Schuster, D. G. (2003). Neurasthenia and a modernizing America. JAMA, 290(17), 2327–2328. https://doi.org/10.1001/jama.290.17.2327.
Sharan, P., & Hans, G. (2021). Cultural issues related to ICD-11 mental, behavioural and neurodevelopmental disorders. Consortium Psychiatricum, 2(2), 7–15. https://doi.org/10.17816/CP67.
Starcevic, V. (1999). Neurasthenia: Cross-cultural and conceptual issues in relation to chronic fatigue syndrome. General Hospital Psychiatry, 21(4), 249–255. https://doi.org/10.1016/S0163-8343(99)00012-2.
Taylor, R. E. (2001). Death of neurasthenia and its psychological reincarnation: A study of neurasthenia at the National Hospital for the Relief and Cure of the Paralysed and Epileptic, Queen Square, London, 1870–1932. British Journal of Psychiatry, 179, 550–557. https://doi.org/10.1192/bjp.179.6.550.
World Health Organization. (1992). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. WHO.
World Health Organization. (2019). Burn-out an occupational phenomenon. WHO.
World Health Organization. (2024). Clinical Descriptions and Diagnostic Requirements for ICD-11 Mental, Behavioural and Neurodevelopmental Disorders. WHO.